相关实验视频

Updated: Jan 7, 2026

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

10.2K

在可切割的皮肤黑色素瘤的辅助和新辅助疗法更新

Matthew J Hadfield1, Sonal Muzumdar2, Ryan J Sullivan3

  • 1Department of Medicine, Division of Hematology/Oncology, The Warren Alpert Medical School of Brown University, Providence, Rhode Island.

Journal of the American Academy of Dermatology
|December 26, 2025
PubMed
概括

免疫检查点抑制剂对早期黑色素瘤治疗有希望. 手术前的新辅助疗法和在II期黑色素瘤中使用可能会改善患者的治疗结果并降低复发风险.

关键词:
在 BRAF 针对性的治疗中,BRAF 提供了针对性的疗法.这是一种BRAF/MEK组合.针对MAPK的向治疗方法.黑色素瘤是一种黑色素瘤.T细胞免疫球蛋白和免疫受体氨酸抑制动机 (TIGIT) 免疫主动体免疫主动体.检查点抑制剂检查点抑制剂达布拉芬尼布的使用情况这里是 ipilimumab 的所在地.淋巴细胞激活基因3 (LAD-3)在mRNA疫苗的使用中.黑色素瘤的辅助疗法治疗.与黑色素瘤相关的新抗原.黑色素瘤新辅助疗法新辅助疗法这就是尼沃卢马布 (nivolumab).型病毒 型病毒编程细胞死亡蛋白1 (PD-1) 编程细胞死亡蛋白1编程死亡连接物-1 (PDL-1)可以切除的黑色素瘤.特拉美丁尼布 (trametinib) 是一种药物.瘤透的淋巴细胞.铁氨基激酶抑制剂 铁氨基激酶抑制剂

更多相关视频

A 3D Organotypic Melanoma Spheroid Skin Model08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

16.5K
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.8K

相关概念视频

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.7K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K